Escobar Gil Tomas, Echavarria Cross Alejandro, Escobar Gil Juan P
Medicine, Universidad CES, Medellín, COL.
Cureus. 2022 Dec 31;14(12):e33181. doi: 10.7759/cureus.33181. eCollection 2022 Dec.
Eosinophilic esophagitis (EoE) is a disease that is still not fully understood. Its pathogenesis, while increasingly clarified, still remains highly complex, which means that no curative treatment has been defined for this clinical entity. It is clear that it is a disease of multifactorial etiology, in which both genetics and environmental factors, especially those related to childhood, have considerable weight, and there is an important allergenic factor as well. We present the case of two brothers with EoE. Two male patients aged 20 and 22 years, white, with a personal history of atopy, allergic rhinitis, and dermatitis, consulted the gastroenterologist for dysphagia. Endoscopy and esophageal biopsy showed elements compatible with EoE in both of them. Treatment was conducted with proton pump inhibitor (PPI) monotherapy in one of the brothers, and PPI with oral steroid in the other, both of which led to good results in terms of symptoms. In the first case, histologic evidence of the disease persisted despite the symptomatic resolution; the second did not pursue a follow-up. The biggest questions pertaining to the treatment of this condition are as follows: Is suppression of gastric acidity enough? Should we use steroids? How about a combination of both? Should we adopt new therapies? New studies involving randomized trials should be conducted to address these questions in order to treat each patient individually with an effective and practical approach that is also supported by the literature.
嗜酸性食管炎(EoE)是一种尚未被完全理解的疾病。其发病机制虽日益明晰,但仍极为复杂,这意味着针对这一临床实体尚未确定治愈性治疗方法。显然,这是一种多因素病因的疾病,其中遗传因素和环境因素,尤其是与儿童期相关的环境因素,具有相当大的影响,并且还存在一个重要的变应原因素。我们介绍两例嗜酸性食管炎兄弟的病例。两名男性患者,年龄分别为20岁和22岁,白人,有特应性、过敏性鼻炎和皮炎的个人病史,因吞咽困难咨询胃肠病学家。内镜检查和食管活检显示两人均有与嗜酸性食管炎相符的表现。其中一名兄弟采用质子泵抑制剂(PPI)单一疗法进行治疗,另一名采用PPI联合口服类固醇进行治疗,两者在症状方面均取得了良好效果。在第一个病例中,尽管症状缓解,但疾病的组织学证据仍然存在;第二个病例未进行随访。与这种疾病治疗相关的最大问题如下:抑制胃酸是否足够?我们应该使用类固醇吗?两者联合使用如何?我们应该采用新的疗法吗?应该进行涉及随机试验的新研究来解决这些问题,以便以一种有效且实用的方法对每位患者进行个体化治疗,这种方法也应得到文献的支持。